Trifene 200

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trifene 200

Quick Facts

Property Description
Active ingredient Ibuprofen
Form Tablets, Coated Pills, Oral Suspension
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic (Propionic Acid Derivative)

What Type of Medicine is Trifene 200?

Trifene 200 is a pharmaceutical preparation classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), intended for the temporary relief of pain and fever. The active component, Ibuprofen, is a synthetic compound derived from propionic acid, which places it within the established chemical group of NSAIDs. This classification is clinically recognized for providing both pain-relieving (analgesic) and inflammation-reducing (anti-inflammatory) effects, distinguishing it from simple pain relievers. The mechanism of action is characterized by Ibuprofen’s role as a reversible inhibitor of cyclooxygenase enzymes.

Composition, Origin, and Form

The therapeutic action of Trifene 200 relies entirely on its single active ingredient, Ibuprofen, typically delivered in a 200 milligram (mg) strength. As a single-ingredient product, it offers focused relief via the established effects of Ibuprofen. The product is primarily designed for oral administration, commonly supplied as tablets or coated pills. A differentiating feature of the Trifene preparation is the availability of an oral suspension alongside solid forms, making the Ibuprofen preparation suitable for a broader patient group. Ibuprofen is designated for the temporary relief of pain and inflammation.

General Purpose and Core Benefits of the Trifene 200 Class

The general therapeutic purpose of Trifene 200 is to provide multifaceted symptomatic relief by targeting the common symptoms of discomfort, not the underlying cause. Its NSAID classification ensures it functions as an analgesic for pain relief, an antipyretic to help reduce an elevated body temperature, and an anti-inflammatory agent to lessen swelling. A typical use scenario for this class involves seeking relief from discomfort associated with muscle strains or symptoms of the common cold.

Regulatory References

  1. MedlinePlus: Ibuprofen Drug Information
  2. DailyMed: Ibuprofen Drug Label

What side effects are possible with Trifene 200?

Possible Side Effects and Safety Information

Trifene 200 contains ibuprofen, a non-steroidal anti-inflammatory drug (NSAID). The safety profile is defined by risks common to this class of medication, requiring strict adherence to recommended dosage and duration.

Adverse Reactions Overview

Adverse effects predominantly affect the Gastrointestinal and Immune Systems. Common but typically mild effects may include indigestion, nausea, vomiting, dizziness, and headache. Serious, though less common, reactions require immediate medical attention.

System-Organ Class Serious or Clinically Significant Adverse Reactions
Gastrointestinal Peptic ulceration, perforation, or bleeding (may be fatal)
Immune/Skin Severe allergic reactions (anaphylaxis), bronchospasm, asthma exacerbation, severe skin reactions (e.g., Stevens-Johnson Syndrome)
Cardiovascular Increased risk of heart attack or stroke, particularly at high doses or with long-term use; precipitation of heart failure

Safety Restrictions and Monitoring

This medication is strictly contraindicated for patients with a history of gastrointestinal bleeding/perforation related to previous NSAID therapy, active or recurrent peptic ulcer/bleeding, severe heart failure (NYHA class IV), or clotting disorders. It is also contraindicated during the last trimester of pregnancy, as NSAIDs can harm the fetus.

To minimize risk, use the lowest effective dose for the shortest duration necessary for symptom relief. The maximum daily dosage is limited to 1200 mg (6 tablets). Continuous, long-term use is not recommended due to increased risks of serious cardiovascular and renal effects. Patients with conditions such as asthma, high blood pressure, mild heart failure, liver or kidney impairment, or those who are elderly require particular caution and medical supervision before use.

Overdose and Emergency Response

The official regulatory profile for Ibuprofen overdose documents a range of clinical manifestations. Symptoms commonly include gastrointestinal effects such as nausea, vomiting, and abdominal pain, alongside central nervous system effects like drowsiness, headache, and confusion.

Overdose Status & Outcomes Officially Documented Findings
Severity The majority of acute overdoses are typically associated with minor, self-limiting symptoms; however, serious and life-threatening complications are officially documented in regulatory reports.
Systemic Risk Officially listed severe outcomes include acute kidney failure, metabolic acidosis, hypotension (low blood pressure), and the potential for convulsions or coma.

Mandated Emergency Actions: Regulatory guidance mandates that users must get medical help or contact a Poison Control Center right away in all instances of overdose, even if the person is currently asymptomatic. Urgent medical attention is required for severe signs, including trouble breathing or sudden weakness. Treatment is formally classified as symptomatic and supportive, given the documented fact that no specific antidote is known for acute NSAID toxicity. Management protocols include monitoring of vital signs and potentially administering activated charcoal for large ingestions.

Therapeutic Uses of Trifene 200

What Trifene 200 Treats: Main Uses and Benefits

Trifene 200 (Ibuprofen) is used in areas where short-term symptom management is appropriate, providing supportive relief across key therapeutic domains. The active ingredient is commonly applied to address symptoms related to physical discomfort, systemic imbalance, and inflammatory states. It is commonly applied in settings where symptoms may intensify temporarily, creating noticeable functional strain.

The medication is helpful in situations requiring additional symptomatic assistance for several common conditions, primarily including headaches, toothaches, recurrent menstrual cramps, muscle pain, and fever associated with colds or the flu. It also assists with discomfort related to temporary flare-ups of certain musculoskeletal issues.

“Applied during phases of increased distress or discomfort, it contributes to easing the overall symptom load.”

Quick Fact: Relief for Key Symptom Axes

Symptom Axis Therapeutic Benefit
Pain and Discomfort Supports patients during difficult episodes by easing distress.
Fever Is relevant for easing symptoms related to systemic imbalance.
Inflammation Is applied in addressing symptoms related to inflammatory or irritative states.

Trifene 200 may assist with easing symptom clusters that can become intense or disruptive, helping patients cope more steadily with symptom fluctuations. The medication helps maintain a sense of stability when symptoms are more noticeable, primarily focusing on conditions characterized by acute or disruptive episodes.

Regulatory References

  1. NIH MedlinePlus overview on Ibuprofen

Eligibility and Restrictions for Use

The eligibility to use Trifene 200 (Ibuprofen) is strictly governed by regulatory classifications based on a patient’s pre-existing health status and physiological condition.

Absolute Contraindications (Must Not Use)

Use is formally prohibited for patients with known hypersensitivity to Ibuprofen or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) that resulted in asthma or urticaria. It is also contraindicated for those with severe heart failure (NYHA Class IV), severe hepatic or renal failure, or a history of recurrent peptic ulceration or gastrointestinal bleeding. Use is strictly prohibited during the third trimester of pregnancy and for pain following Coronary Artery Bypass Graft (CABG) surgery.

Age and Restricted Use

The medicine is contraindicated for children under 6 years of age or weighing less than 20 kg. Older adults must use the lowest effective dose for the shortest duration due to an increased risk of adverse effects.

Conditional use is required for patients with mild to moderate hepatic or renal impairment or those with conditions like uncontrolled hypertension or inflammatory bowel disease (which may be exacerbated). Use is not recommended during the first or second trimesters of pregnancy or for women actively attempting to conceive.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Trifene 200 (Ibuprofen) interacts with various medicines and substances through documented pharmacokinetic and pharmacodynamic mechanisms, strictly as stated in official government regulatory documents.

Official Interaction Statements

  • Contraindicated Combinations: Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 inhibitors, is formally prohibited due to the officially documented heightened risk of gastrointestinal adverse events. Use is also restricted for pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Exposure Modification: Ibuprofen is documented to reduce the renal clearance of Lithium and Methotrexate, which may result in increased plasma concentrations of these medicines. Plasma levels of Cardiac Glycosides may also be officially increased.
  • Pharmacodynamic Risk: Concomitant use with Anticoagulants, Oral Corticosteroids, Anti-platelet agents, and SSRIs may officially enhance the risk of serious bleeding or gastrointestinal ulceration, a key concern outlined in regulatory labeling.
  • Efficacy Counteraction: Ibuprofen may officially diminish the desired effect of Antihypertensives (e.g., ACE inhibitors, ARBs) and Diuretics. It may also competitively inhibit the anti-platelet effect of low-dose Aspirin when administered concurrently.
  • Timing Constraints: NSAIDs should not be used for 8–12 days following Mifepristone administration, as this is officially documented to reduce the effect of Mifepristone. Consumption of three or more alcoholic drinks daily is officially associated with an increased risk of serious gastrointestinal bleeding.
  • Population Notes: The risk of renal impairment when combined with ACE inhibitors or ARBs is officially noted to be elevated in elderly or volume-depleted patients.

Mechanism of Action

How Trifene 200 Works

Trifene 200 (Ibuprofen) exerts its mechanism of action through the non-selective, reversible inhibition of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This molecular interaction blocks the primary step in the Arachidonic Acid Cascade, thereby preventing the biosynthesis of lipid mediators known as prostaglandins ( PGs).

Reduced PGE2 concentration triggers two distinct physiological consequences: a peripheral action that modulates the sensitization of nociceptive nerve endings, and a central action on the hypothalamus. Within the hypothalamus, this mechanism causes the correction of the elevated thermoregulatory set-point and alters the central signaling of thermal stimuli. The dual peripheral and central action alters the processing of nociceptive and thermal stimuli across the system.

The non-selective mechanism includes the reduction of PGs synthesized by the constitutive COX-1 enzyme. This impacts homeostatic mechanisms, including the integrity of the gastrointestinal mucosa and the regulation of renal blood flow. The drug's effect targets the mediators of the physiological response rather than the underlying pathological process.

Dosage and Administration Information

How to Use Trifene 200: General Administration

This section describes the high-level instructions for using Trifene 200 (Ibuprofen). Usage is structured around specific parameters concerning administration, dosage, frequency, and time limitations.


Administration Scope

Entity Instruction
Route of administration The primary route for this preparation is oral (by mouth), encompassing tablets, coated pills, and oral suspensions.
Dosing schedule (Adults) Single Dose: 200 mg to 400 mg. Maximum Daily Dose (OTC Use): Do not exceed 1200 mg in 24 hours.
Timing in relation to meals Administration is generally advised with food or milk, or directly after a meal, to help minimize potential gastrointestinal discomfort.
Preparation requirements Liquid oral suspensions require shaking before the dose is measured and administered.
Age-group rules Older Adults: Instructions involve the use of the lowest effective dose for the shortest duration possible due to increased sensitivity.
Special conditions A minimum interval of at least 4 hours is required between individual doses. Use of the lowest dose for the shortest time necessary is standard.

Connection to the Use Protocol

The usage protocol establishes a defined framework for the oral administration of Trifene 200, governing the amount, timing, and duration of use. This sequence involves taking the required dose orally, often alongside food, at a regulated interval (e.g., every 4 to 6 hours), subject to a total daily maximum. Adherence to these quantitative and procedural parameters ensures consistency with standard product information.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Trifene 200

Evidence for Use in Acute Pain and Headaches

The research base supporting the use of the active ingredient in Trifene 200 was evaluated in studies exploring how symptoms change over time in conditions associated with acute or disruptive episodes. This primarily includes short-term Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies monitored outcomes related to physical discomfort across defined intervals (e.g., four to eight hours), often using controlled models such as post-operative dental procedures.

Research also examined the use of the active ingredient for headaches, including episodic tension-type headache and migraine. Studies monitored outcomes describing episodic or acute changes, such as the proportion of participants who reported a change in pain intensity over a short period. Findings described patterns related to changes in measured pain intensity over the observation period for single-dose administration.


Evidence for Use in Fever and Recurrent Pain

This area will outline the study designs, such as comparative trials and systematic reviews, that tracked temperature changes in febrile patients and evaluated acute pain relief in recurrent conditions like primary menstrual cramps.

The active ingredient was studied for outcomes related to systemic or functional imbalance (fever). Trials and systematic reviews explored short-term symptom changes by monitoring the reduction in elevated body temperature at defined post-dose time points. Comparative research describes patterns related to temperature changes when monitored against another compound studied for the same outcomes.

For conditions characterized by recurrent menstrual cramps (primary dysmenorrhea), the active ingredient was studied in randomized trials. These studies examined patient-reported outcomes describing perceived discomfort and cramping pain severity across one to three menstrual cycles. Research highlights changes measured during the study period, with findings describing patterns related to pain scores in the acute phase of the menstrual episode.


Long-Term Studies and Follow-Up

Clinical evidence primarily available for Trifene 200 and its active ingredient focuses on acute symptom patterns over short timeframes. Most supporting research involves observation periods of less than one day or up to a few days. There is limited information for long-term outcomes regarding the repeated, intermittent use of this specific 200 mg strength over months or years. Follow-up durations were limited; research exploring short-term symptom changes offers less insight into maintenance or sustained outcomes.


What is Still Uncertain About the Research Base

While a substantial body of research exists, some limitations in the evidence base should be noted. Evidence quality varies across studies, and sample sizes were modest in older trials. Comparative evidence is lacking for certain headache subtypes or specific muscular strains. Furthermore, the 200 mg strength is often assessed as part of a larger dose-range study, meaning data focusing exclusively on this single dose strength for all indications can be heterogeneous.

Frequently Asked Questions (FAQ)

Common questions about Trifene 200 (FAQ)

Q: How quickly should I expect Trifene 200 to start working?

Clinical information from regulatory authorities indicates that the active ingredient in Trifene 200 typically begins to work within an hour of administration. This indicates the expected timeframe for the active component to start affecting symptoms.

Q: How long does the effect of Trifene 200 typically last?

Official product information describes the duration of effect based on the condition being addressed. For pain relief, the effects generally last for 4 to 6 hours. For fever reduction, relief may last slightly longer, generally up to 8 hours.

Q: What is the maximum number of days a person usually takes Trifene 200?

Official guidelines recommend limiting the duration of use for temporary symptom relief. Typically, the product should not be used for pain for more than 5 consecutive days, or for fever for more than 3 days, without first consulting a healthcare professional. These limitations are described in official safety information.

Q: Does Trifene 200 affect sleep or cause drowsiness?

Regulatory documents list central nervous system effects such as drowsiness, insomnia (difficulty sleeping), and nervousness as less common or infrequent side effects associated with this type of medicine. These effects are listed within the official safety documentation.

Q: Is it known whether Trifene 200 interacts with common herbal supplements?

The FDA and other regulatory bodies warn that certain dietary supplements, including herbal products, can interact with medications and potentially change their effects. Because of the wide variety of supplements available, official guidance notes the importance of a healthcare professional reviewing potential interactions with any specific herbal products.

Q: Is there a risk of dependency or addiction with Trifene 200?

Ibuprofen is not traditionally classified as an addictive substance, unlike certain stronger prescription pain medications. However, official information notes that misuse or excessive reliance on any over-the-counter pain reliever can sometimes lead to rebound symptoms, such as headache, upon discontinuing the medication.

Q: Can Trifene 200 be taken at the same time as cold or flu remedies?

It is formally prohibited to combine Trifene 200 with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) to avoid increased side effect risks. Regulatory warnings emphasize the need to review the label of any combined remedy to ensure that other NSAIDs are not inadvertently taken.

Q: What are the signs that someone should stop taking Trifene 200 and seek medical attention?

Official guidance emphasizes seeking immediate medical help for any signs of serious bleeding (such as passing black or bloody stools, or vomiting material that looks like coffee grounds) or severe allergic reactions (such as sudden trouble breathing, wheezing, or swelling of the face). These are examples of serious adverse reactions described in official safety documents.

Q: What is known about using Trifene 200 while breastfeeding?

Expert lactation sources note that the active ingredient, ibuprofen, is considered a preferred choice for pain or inflammation relief in nursing mothers. This assessment is based on reports of very low levels of the active component found in breastmilk.

Q: Does Trifene 200 cause thinning of the blood, according to official information?

Ibuprofen can affect the blood’s ability to clot due to its antiplatelet effect. Official information notes that this effect contributes to the documented risk of bleeding episodes, particularly when the medication is combined with other agents that also reduce clotting, often referred to as 'blood-thinning' medicines.

Q: If I miss a planned use of Trifene 200, what does official guidance say?

Official guidance states that if a dose is missed, it should generally be used when remembered. However, if the time is close to the next planned use, the instruction is to proceed with the next scheduled use. Official regulatory information cautions against doubling a dose.

Q: Are there common signs of too much Trifene 200 being used?

Signs associated with excessive use or overdose are documented in regulatory sources and may include drowsiness, dizziness, severe headache, ringing in the ears (tinnitus), nausea, vomiting, and stomach pain. Any suspected signs of excessive use are typically advised to be reviewed by a healthcare professional.

Q: Are there any known common interactions between Trifene 200 and antacids?

While often used together to alleviate stomach irritation, some antacids may slightly affect how quickly the body absorbs ibuprofen. Official warnings also note that antacids may contain aspirin, which is formally prohibited with Trifene 200 and could lead to potential adverse interactions.

Q: What is known about the relationship between Trifene 200 and sun exposure?

Ibuprofen, like other medications in its class, has been reported as a photosensitizing agent. This means it may potentially increase your skin's sensitivity to sunlight. Official information notes that heightened sensitivity to sunlight is a documented possibility with this class of medicine.

Q: What steps are officially described if a side effect occurs while using Trifene 200?

Official guidance requires users to seek medical advice as soon as possible if they experience any suspected side effects. Furthermore, regulatory bodies encourage the reporting of new safety information, especially severe symptoms like stomach pain, significant rash, or breathing issues, to relevant health authorities.

How should Trifene 200 be stored and disposed of?

Storage Conditions

Official regulatory documents require that Trifene 200 (Ibuprofen) be stored at Controlled Room Temperature, typically defined as 20 C to 25 C (68 F to 77 F). The product must be kept in its original container and protected from excessive heat and moisture, as storage in high-humidity areas is strictly prohibited. For safety, the medicine must be kept out of the sight and reach of children at all times.

Storage Restriction Requirement
Temperature Store below 25 C/Avoid temperatures above 40 C
Protection Store in original container; protect from light and moisture
Child Safety Keep out of the reach and sight of children

Disposal Instructions

Unused or expired Trifene 200 must be disposed of according to official guidelines. The preferred method is using a drug take-back program or an authorized mail-back option. Disposal into wastewater (flushing down the toilet or pouring down the sink) is prohibited. If a take-back program is unavailable, the medicine should be mixed with an unappealing substance, sealed in a container, and discarded in the household trash, with all personal information removed from the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trifene 200 found in:

A-Z Index: